Logo image of BELYS.BR

BELYSSE GROUP NV (BELYS.BR) Stock Fundamental Analysis

Europe - Euronext Brussels - EBR:BELYS - BE0974314461 - Common Stock

0.8 EUR
-0.02 (-3.03%)
Last: 1/16/2026, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BELYS. BELYS was compared to 32 industry peers in the Household Durables industry. BELYS may be in some trouble as it scores bad on both profitability and health. BELYS has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

  • In the past year BELYS has reported negative net income.
  • In the past year BELYS had a positive cash flow from operations.
  • In the past 5 years BELYS reported 4 times negative net income.
  • Of the past 5 years BELYS 4 years had a positive operating cash flow.
BELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFBELYS.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

  • BELYS has a worse Return On Assets (-0.02%) than 62.50% of its industry peers.
  • BELYS has a Return On Equity of -0.07%. This is in the lower half of the industry: BELYS underperforms 62.50% of its industry peers.
  • BELYS has a better Return On Invested Capital (6.48%) than 65.63% of its industry peers.
  • BELYS had an Average Return On Invested Capital over the past 3 years of 7.13%. This is below the industry average of 9.71%.
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROIC 6.48%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
BELYS.BR Yearly ROA, ROE, ROICBELYS.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -50 -100

1.3 Margins

  • Looking at the Operating Margin, with a value of 6.94%, BELYS is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BELYS has declined.
  • The Gross Margin of BELYS (61.34%) is better than 84.38% of its industry peers.
  • BELYS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.94%
PM (TTM) N/A
GM 61.34%
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
BELYS.BR Yearly Profit, Operating, Gross MarginsBELYS.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BELYS is destroying value.
  • Compared to 1 year ago, BELYS has about the same amount of shares outstanding.
  • The debt/assets ratio for BELYS has been reduced compared to a year ago.
BELYS.BR Yearly Shares OutstandingBELYS.BR Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M
BELYS.BR Yearly Total Debt VS Total AssetsBELYS.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • BELYS has an Altman-Z score of 0.27. This is a bad value and indicates that BELYS is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of 0.27, BELYS is not doing good in the industry: 90.63% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of BELYS is 4.98, which is a neutral value as it means it would take BELYS, 4.98 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 4.98, BELYS is in the better half of the industry, outperforming 68.75% of the companies in the same industry.
  • BELYS has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
  • BELYS's Debt to Equity ratio of 1.80 is on the low side compared to the rest of the industry. BELYS is outperformed by 90.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Altman-Z 0.27
ROIC/WACC0.6
WACC10.88%
BELYS.BR Yearly LT Debt VS Equity VS FCFBELYS.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • A Current Ratio of 1.63 indicates that BELYS should not have too much problems paying its short term obligations.
  • BELYS's Current ratio of 1.63 is in line compared to the rest of the industry. BELYS outperforms 56.25% of its industry peers.
  • A Quick Ratio of 0.90 indicates that BELYS may have some problems paying its short term obligations.
  • BELYS's Quick ratio of 0.90 is in line compared to the rest of the industry. BELYS outperforms 56.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 0.9
BELYS.BR Yearly Current Assets VS Current LiabilitesBELYS.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

2

3. Growth

3.1 Past

  • BELYS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -100.85%.
  • The Revenue has decreased by -6.81% in the past year.
  • Measured over the past years, BELYS shows a small growth in Revenue. The Revenue has been growing by 0.43% on average per year.
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%

3.2 Future

  • BELYS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.41% yearly.
  • The Revenue is expected to grow by 0.36% on average over the next years.
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BELYS.BR Yearly Revenue VS EstimatesBELYS.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
BELYS.BR Yearly EPS VS EstimatesBELYS.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

5

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Forward Earnings ratio is 4.31, which indicates a rather cheap valuation of BELYS.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of BELYS indicates a rather cheap valuation: BELYS is cheaper than 96.88% of the companies listed in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.29. BELYS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 4.31
BELYS.BR Price Earnings VS Forward Price EarningsBELYS.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • BELYS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BELYS is cheaper than 93.75% of the companies in the same industry.
  • 100.00% of the companies in the same industry are more expensive than BELYS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.91
EV/EBITDA 3.86
BELYS.BR Per share dataBELYS.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%

0

5. Dividend

5.1 Amount

  • No dividends for BELYS!.
Industry RankSector Rank
Dividend Yield 0%

BELYSSE GROUP NV

EBR:BELYS (1/16/2026, 7:00:00 PM)

0.8

-0.02 (-3.03%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)10-20
Earnings (Next)03-05
Inst Owners12.65%
Inst Owner ChangeN/A
Ins Owners5.56%
Ins Owner ChangeN/A
Market Cap28.75M
Revenue(TTM)270.29M
Net Income(TTM)-59.00K
Analysts84.44
Price Target1.63 (103.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.31
P/S 0.11
P/FCF 0.91
P/OCF 0.7
P/B 0.35
P/tB N/A
EV/EBITDA 3.86
EPS(TTM)0
EYN/A
EPS(NY)0.19
Fwd EY23.17%
FCF(TTM)0.88
FCFY109.77%
OCF(TTM)1.15
OCFY143.28%
SpS7.52
BVpS2.28
TBVpS-0.59
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -0.02%
ROE -0.07%
ROCE 7.91%
ROIC 6.48%
ROICexc 7.66%
ROICexgc 15.72%
OM 6.94%
PM (TTM) N/A
GM 61.34%
FCFM 11.68%
ROA(3y)-6.3%
ROA(5y)-7.85%
ROE(3y)-25.25%
ROE(5y)-43.19%
ROIC(3y)7.13%
ROIC(5y)5.99%
ROICexc(3y)9.09%
ROICexc(5y)7.47%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.69%
ROCE(5y)7.3%
ROICexgc growth 3Y21.04%
ROICexgc growth 5YN/A
ROICexc growth 3Y8.96%
ROICexc growth 5YN/A
OM growth 3Y-5.23%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.7%
GM growth 5YN/A
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 4.98
Debt/EBITDA 3.8
Cap/Depr 48.2%
Cap/Sales 3.56%
Interest Coverage 1.25
Cash Conversion 106.31%
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 0.9
Altman-Z 0.27
F-Score4
WACC10.88%
ROIC/WACC0.6
Cap/Depr(3y)58.36%
Cap/Depr(5y)60.35%
Cap/Sales(3y)3.69%
Cap/Sales(5y)3.85%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-100.85%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100.76%
EPS Next Y-70.83%
EPS Next 2Y-13.4%
EPS Next 3Y-1.41%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.81%
Revenue growth 3Y0.43%
Revenue growth 5YN/A
Sales Q2Q%-6.97%
Revenue Next Year-3.57%
Revenue Next 2Y-0.54%
Revenue Next 3Y0.36%
Revenue Next 5YN/A
EBIT growth 1Y-18.43%
EBIT growth 3Y-4.83%
EBIT growth 5YN/A
EBIT Next Year68.18%
EBIT Next 3Y25.03%
EBIT Next 5YN/A
FCF growth 1Y114.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.99%
OCF growth 3YN/A
OCF growth 5YN/A

BELYSSE GROUP NV / BELYS.BR FAQ

What is the fundamental rating for BELYS stock?

ChartMill assigns a fundamental rating of 3 / 10 to BELYS.BR.


Can you provide the valuation status for BELYSSE GROUP NV?

ChartMill assigns a valuation rating of 5 / 10 to BELYSSE GROUP NV (BELYS.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for BELYSSE GROUP NV?

BELYSSE GROUP NV (BELYS.BR) has a profitability rating of 3 / 10.


What is the financial health of BELYSSE GROUP NV (BELYS.BR) stock?

The financial health rating of BELYSSE GROUP NV (BELYS.BR) is 3 / 10.